MONTGOMERY — The jury is out in the Medicaid pharmaceutical fraud trial in Montgomery, with the attorney for the state asking for $39 million in compensatory damages and between $140 million and $250 million in punitive damages.

Alabama sued the drug manufacturer AstraZeneca and about 75 other drug manufacturers alleging they overcharged Alabama’s Medicaid program for prescription drugs.

AstraZeneca, the first company to go to trial, said it is not liable because it doesn’t sell directly to the state.

Plaintiff’s attorney Jere Beasley, who was hired by the state, asked the jury after closing arguments for $28 million in compensatory damages plus $11 million in interest and an additional $140 million to $250 million in punitive damages to punish the company for its alleged behavior.

The trial started last week.